Ireland· IE-PA-EU/1/04/292/001-004

Mimpara 30 mg film-coated tablets

A cinacalcet product containing cinacalcet hydrochloride, registered in Ireland by Amgen Europe B.V.,. The same ATC class is registered in 19 of our 19 countries.

ATC H05BX01

Checked against HPRA (Ireland) on June 15, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cinacalcet hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cinacalcet is registered in 19 of 19 countries.

Countries holding a registration under ATC H05BX01 (cinacalcet), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
11 of them publish a price we can compare per daily dose

Search cinacalcet products by name

Cinacalcet · ATC H05BX01

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cinacalcet costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $1.87 in Italy to $9.84 in Switzerland — a ×5.3 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cinacalcet · price per daily dose (60 mg)

USD · FX 28 Sept 2026

CH Switzerland$9.84
FR France$5.46
IT Italy$1.87

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Cinacalcet hydrochloride
Manufacturer: Amgen Europe B.V.,
Country: Ireland (IE)
ATC code: H05BX01
ATC class: Cinacalcet
Defined daily dose: 60 mg, O
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: June 15, 2026

Packs & prices · 1

ie_pa_number
EU/1/04/292/001-004

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

284 interactions on record for cinacalcet.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cinacalcet against other medicines How interaction checks work

Cinacalcet · interactions on record

284 records

14 severe
125 moderate
3 minor
142 info

Most severe, free to view

EliglustatA16AX10severe
EtelcalcetideH05BX04severe
TamoxifenL02BA01severe
OliceridineN02AX07severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cinacalcet in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cinacalcet products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

Austria · Cinacalcet Medice, Cinacalcet Pharmsol
Belgium · Cinacalcet Ab
Bulgaria · Синакалцет Тева, Синакалцет Хитън
Cyprus · Cinacalcet (Ωσ Hydrochloride) Pharmazac, Cinacalcet Rafarm
Czechia · Cinacalcet Heaton, Cinacalcet Stada
Germany · Cinacalcet Al, Cinacalcet Amarox
Denmark · Cinacalcet Amarox, Cinacalcet Glenmark
Spain · Cinacalcet Abdi, Cinacalcet Aurovitas
Finland · Cinacalcet Accord, Cinacalcet Orion
France · Cinacalcet Arrow, Cinacalcet Bgr
United Kingdom (Northern Ireland) · Cinacalcet Abdi, Cinacalcet Amarox
Greece · Calcedem, Cinacalcet Faran
Hungary · Cinacalcet Onkogen
Iceland · Cinacalcet Accordpharma, Cinacalcet Stada
Italy · Cinacalcet Abdi, Cinacalcet Aurobindo
Liechtenstein · Cinacalcet Accordpharma, Cinacalcet Viatris
Malta · Cinacalcet Clonmel, Cinacalcet Heaton
Netherlands · Calcedem, Cinacalcet Abdi
Norway · Cinacalcet, Cinacalcet Accordpharma
Poland · Cinacalcet Aurovitas
Portugal · Cinacalcet Basi, Cinacalcet Generis
Romania · Cinacalcet Heaton
Sweden · Cinacalcet Amarox, Cinacalcet Glenmark
Slovakia · Cinacalcet Heaton, Cinacalcet Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/a95e3260-415e-49a4-a926-b927d35dc9f6
GET /v1/drugs/a95e3260-415e-49a4-a926-b927d35dc9f6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "H05BX",
    "H05BX01"
  ],
  "strength": null,
  "pa_number": "EU/1/04/292/001-004",
  "substances": [
    "Cinacalcet hydrochloride"
  ],
  "legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": null,
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0134-033-003"
}

API reference MCP server Plans

See everything about cinacalcet.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console